Skip to content Skip to sidebar Skip to footer

Symptoms

Symptoms of Parkinson’s Disease

A comprehensive, evidence-based review of the full spectrum of motor and non-motor symptoms in Parkinson’s disease — from the cardinal movement features to the complex array of systemic manifestations.


3.1 Motor Symptoms — The Cardinal Features (TRAP)

The four cardinal motor features of PD are collectively remembered with the acronym TRAP:

Tremor

The classic PD tremor is a resting tremor — occurring when the affected limb is fully supported and at rest — with a characteristic frequency of 4–6 Hz. It typically begins unilaterally in the hand (“pill-rolling tremor,” as if rolling a small object between the thumb and index finger) and may spread to the ipsilateral leg, jaw, or lip. Crucially, rest tremor diminishes with voluntary movement and worsens with stress or mental distraction. Approximately 70–75% of PD patients present with tremor at onset, though ~25% never develop prominent tremor (the “akinetic-rigid” variant) (Hughes et al., 1992, Journal of Neurology, Neurosurgery & Psychiatry).

Rigidity

Rigidity is increased resistance to passive movement of a limb across its full range of motion, present in both flexion and extension directions. It is uniform throughout the range of movement (“lead-pipe rigidity”) or, when superimposed with tremor, may have a ratchet-like quality (“cogwheel rigidity”). Rigidity contributes to the characteristic stooped posture, masked facies (reduced facial expression), reduced arm swing, and the micrographia (small handwriting) seen in PD. It can cause significant pain, particularly in the shoulder — PD is a not-uncommon cause of misdiagnosed “frozen shoulder.”

Akinesia / Bradykinesia

Bradykinesia (slowness of movement) is the most disabling cardinal feature and is required for a PD diagnosis according to MDS criteria. Akinesia (poverty of movement) and hypokinesia (reduced amplitude of movement) are related manifestations. Clinically, bradykinesia is assessed by repetitive movements (finger tapping, hand opening/closing, foot tapping) which show progressive decrement in speed and amplitude. It manifests functionally as: difficulty with fine motor tasks (buttoning, writing, cutting food); reduced blinking; soft speech (hypophonia); difficulty swallowing; slowed gait; and loss of automatic movements (arm swing, facial expression).

Postural Instability

Postural instability — impaired righting reflexes and balance — typically emerges later in the disease course (usually after 5–10 years) and is a major source of disability and falls. The “pull test” (sudden backward pull on the shoulders) reveals impaired postural responses. Falls affect up to 70% of PD patients annually and are the leading cause of hospitalization and injury, including hip fracture, head trauma, and death (Allen et al., 2013, Movement Disorders).

3.2 Additional Motor Features

  • Freezing of gait (FOG): Sudden, transient inability to initiate or continue walking, as if the feet are “glued” to the floor. Particularly common at doorways, turns, and narrow spaces. Affects ~50% of patients after 10 years and is a major fall risk.
  • Festination: Involuntary acceleration of gait with increasingly small steps, as if chasing one’s center of gravity forward.
  • Camptocormia: Pathological forward flexion of the trunk, often severe enough to cause the patient to be nearly parallel to the ground while walking.
  • Dysarthria: Motor speech disorder causing soft, monotone, rapid speech with reduced articulation (hypokinetic dysarthria).
  • Dysphagia: Swallowing difficulties, affecting up to 80% of PD patients at some stage; a major risk factor for aspiration pneumonia, the most common cause of death in PD.
  • Micrographia: Progressive shrinkage of handwriting — often one of the earliest self-reported motor symptoms.

3.3 Non-Motor Symptoms

Non-motor symptoms (NMS) are present in virtually all PD patients and are increasingly recognized as the primary determinants of quality of life, caregiver burden, and nursing home placement. Critically, many NMS predate motor symptoms by years or decades — the so-called “prodromal” or “premotor” phase of PD.

DomainSymptomPrevalenceClinical Notes
NeuropsychiatricDepression40–50%Often preceding motor onset; related to dopaminergic and serotonergic deficits
Anxiety30–40%Generalized anxiety, panic attacks; often worse in “off” states
Apathy40–45%Distinct from depression; loss of motivation without sadness; dopaminergic deficit
Hallucinations20–40%Usually visual; associated with disease duration, cognition, cholinergic deficit
Impulse control disorders10–15%Pathological gambling, hypersexuality, binge eating — dopamine agonist side effects
CognitiveMild cognitive impairment20–30% at diagnosisExecutive dysfunction most common; visuospatial, memory also affected
PD Dementia80% after 20 yearsLewy body pathology spread to neocortex; Cholinesterase inhibitors modestly effective
SleepREM sleep behavior disorder40–60%Acting out dreams; often precedes PD by decades; high conversion rate to synucleinopathy
Insomnia60–70%Multifactorial: nocturia, pain, depression, medications, nocturnal motor symptoms
Excessive daytime sleepiness50–75%Dopamine agonist side effect; also intrinsic to disease
AutonomicConstipation50–80%Often precedes motor symptoms by 10–20 years; enteric alpha-synuclein accumulation
Orthostatic hypotension30–50%BP drop ≥20/10 mmHg on standing; fall risk; worsened by levodopa, dopamine agonists
Urinary dysfunction50–60%Urgency, frequency, nocturia; overflow incontinence in advanced disease
Sexual dysfunction40–80%Erectile dysfunction in men; reduced libido in both sexes
Sweating abnormalities40–50%Hyperhidrosis (“on” states), hypohidrosis; heat intolerance
SensoryAnosmia/hyposmia70–90%Among earliest PD features; useful prodromal biomarker
Pain40–85%Musculoskeletal, neuropathic, dystonic, central sensitization
Vision changes20–30%Reduced contrast sensitivity, color discrimination, convergence difficulties
OtherFatigue40–60%Physical and mental fatigue; independent of motor severity, depression, or sleep
Weight loss40–50%Multifactorial: dysphagia, increased energy expenditure, reduced appetite
Sialorrhea (drooling)50–75%Due to dysphagia, not overproduction of saliva; botulinum toxin injection effective

References: Allen et al. (2013) Movement Disorders; Hughes et al. (1992) JNNP; Postuma et al. (2015) Movement Disorders; Schapira et al. (2017) Nature Reviews Disease Primers.

Navigation: ← Epidemiology | Causes & Risk Factors →